Clinical Trial Update: N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating N-acetylcysteine and milk thistle for diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Milk Thistle (silymarin)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetic Nephropathies, Proteinuria | Phase 2 | Status: COMPLETED